Injectable platelet-rich fibrin is one of 2 therapeutic programs targeting Temporomandibular Disorder. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1 competitor in Temporomandibular Disorder
Platelet Rich Plasma
Injectable platelet-rich fibrin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details